Government Affairs
Refine Search
Pharmaceutical
Medical industry body Medicines Australia and other industry representatives have appeared before the Australian Senate inquiry into new, innovative and specialist oncology drugs in the country. 20 April 2015
Generics
At the urging of US Senator Bernie Sanders and Representative Elijah Cummings, the Department of Health and Human Services’ Inspector General has agreed to investigate how sudden price hikes by generic drug makers are driving up the cost of taxpayer-supported health care. 16 April 2015
Pharmaceutical
The chairman of India’s National Pharmaceutical Pricing Authority has been removed from his position. 10 April 2015
Pharmaceutical
The Russian government plans to approve a new plan of import substitution in the national pharmaceutical industry shortly, according to Sergey Tsyb, Russia’s Deputy Minister of Industry and Trade, reports The Pharma Letter’s local correspondent. 1 April 2015
Generics
The French government has launched a national action plan to promote the use of generic medicines, aiming for a saving of 350 million euros ($375 million) by 2017. 1 April 2015
Pharmaceutical
The US government has announced a five-year plan to fight the antibiotic-resistant bacteria crisis. 30 March 2015
Pharmaceutical
Leading Ukrainian pharmaceutical producers have called on the national government to revise the earlier adopted decision to provide preferences to foreign drugmakers over local firms during the state tenders for the purchase of drugs. 27 March 2015
Pharmaceutical
The Ukrainian pharma organization, the Association of Pharmaceutical Research and Development (APRaD) has visited Brussels to meet with the EFPIA and other European Commission services to discuss the advancement of healthcare reform in Ukraine. 23 March 2015
Pharmaceutical
Faced with the problem that has arisen in the last few months with regards to the access to new treatments for hepatitis C, as well as with the information and opinions expressed, sometimes contradictory, on these new medicines, Spanish pharma trade group Farmaindustria says it would like to thoroughly support the government and offer its collaboration with the aim of making an accurate diagnosis of the number of patients who need to be treated. 23 March 2015
Pharmaceutical
The UK BioIndustry Association (BIA) welcomes statements made in today’s Budget announced by UK Chancellor of the Exchequer George Osborne, supporting previous BIA calls for change in respect of small and medium-sized enterprises (SME) access to R&D tax credits as well as the operation of tax-advantaged venture capital schemes. 18 March 2015
Pharmaceutical
The Russian government may allow parallel imports (imports of non-counterfeit product from another country without the permission of the intellectual property owner) of drugs to Russia, according to Andrey Kashevarov, Deputy Head of the Russian Federal Anti-Monopoly Service (FAS), reports The Pharma Letter’s Russia correspondent. 17 March 2015
Pharmaceutical
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is concerned about the Minister of Health’s decision to proceed with a further 8.5% horizontal price cut on private sector medicines. 17 March 2015
Generics
The Russian General's Prosecutor Office has issued a warning to a local firm Veropharm, one of Russia’s leading drugmakers, (which was recently acquired by the USA’s Abbott Laboratories about the permissibility of compliance with any anti-Russian sanctions. 16 March 2015
Pharmaceutical
The Trans Pacific Partnership Agreement (TPP) will open up vast new markets for Australian companies, including manufacturers of innovative medicines and vaccines, says trade group Medicines Australia’s chief executive, Tim James. 16 March 2015
Biosimilars
After months of uncertainty, the Spanish Ministry of Health has announced its new policy for the biosimilars of monoclonal antibody (MAb) drugs. 12 March 2015
Pharmaceutical
The recent outbreak of infections and death caused by the influenza A H1N1 strain across India has turned the spotlight on the country's ailing health care system. 9 March 2015
article
Russian drugmakers and some foreign producers operating in the country may fix prices for their drugs in Russia, in exchange for signing of long-term contracts with the state, according to Olga Golodets, Russia’s Deputy Prime Minister. 9 March 2015
Pharmaceutical
On March 3, the Ministry of Health of Ukraine and international research-based pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Association of Pharmaceutical Research and Development (APRAD) entered into a Letter of Intent. 9 March 2015
Pharmaceutical
The political establishment needs to concentrate on cleaning up its own act and concentrating on their own critical matters, before getting involved with the 'golden hello' offered to Olivier Brandicourt by Sanofi, says Mark Bloomfield, chief executive of French biotech firm Polyplus. 4 March 2015
Pharmaceutical
US Senators Chris Coons (Democrat, Delaware) and Dick Durbin (Democrat, Illinois), members of the Senate Judiciary Committee, and Mazie Hirono (Democrat, Hawaii), member of the Senate Committee on Small Business and Entrepreneurship, have introduced legislation to strengthen America’s patent system and target abusers. 4 March 2015
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze